Study of Patient with frequent exacerbations in Moscow

Trial Identifier:	D2287R00217
Sponsor:	AstraZeneca
Start Date:	December 2025
Primary Completion Date:	June 2027
Study Completion Date:	June 2027
Condition:	Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Russia	Moscow, Russia

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.